H Pylori
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 15, 2004; 10(16): 2340-2343
Published online Aug 15, 2004. doi: 10.3748/wjg.v10.i16.2340
Antigen epitope of Helicobacter pylori vacuolating cytotoxin A
Xiu-Li Liu, Shu-Qin Li, Chun-Jie Liu, Hao-Xia Tao, Zhao-Shan Zhang
Xiu-Li Liu, Shu-Qin Li, Chun-Jie Liu, Hao-Xia Tao, Zhao-Shan Zhang, Bejing Institute of Biotechnology, Beijing 100071, China
Author contributions: All authors contributed equally to the work.
Supported by the National High Technology Research and Development Program of China (863 Program), No. 2001AA215161
Correspondence to: Zhao-Shan Zhang, Bejing Institute of Biotechnology, 20 Dongdajie Street, Fengtai District, Beijing 100071, China. zhangzs@nic.bmi.ac.cn
Telephone: +86-10-66948834 Fax: +86-10-63833521
Received: February 11, 2004
Revised: February 15, 2004
Accepted: February 24, 2004
Published online: August 15, 2004
Abstract

AIM: To construct and select antigen epitopes of vacuolating cytotoxin A (VacA) for nontoxic VacA vaccine against Helicobacter pylori (H pylori ) infection.

METHODS: Eleven VacA epitopes were predicted according to VacA antigenic bioinformatics. Three candidates of VacA epitope were constructed through different combined epitopes. The candidate was linked with E. coli heat-labile enterotoxin B (LTB) by a linker of 7 amino acids, and cloned into plasmid pQE-60 in which fusion LTB-VacA epitope was efficiently expressed. To test the antigencity of the candidate, 6 BALB/c mice were treated with the fusion LTB-VacA epitope through intraperitoneal injection. To explore the ability of inhibiting the toxicity of VacA,cantiserum against the candidate was used to counteract VacA that induced HeLa cells to produce cell vacuoles in vitro.

RESULTS: Serum IgG against the candidate was induced in the BALB/c mice. In vitro, the three antisera against the candidate efficiently counteracted the toxicity of VacA, and decreased the number of cell vacuoles by 14.17%, 20.20% and 30.41% respectively.

CONCLUSION: Two of the three candidates, LZ-VacA1and LZ-VacA2, can be used to further study the mechanism of vacuolating toxicity of VacA, and to construct nontoxic VacA vaccine against H pylori infection.

Keywords: $[Keywords]